证券代码：600735 证券简称：新华锦 公告编号：2025-036 山东新华锦国际股份有限公司 第十三届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 山东新华锦国际股份有限公司（以下简称"公司"）第十三届董事会第十七次 会议于 2025 年 7 月 31 日在青岛市崂山区松岭路 131 号 17 楼会议室以现场和通讯方 式召开，会议通知已于 2025 年 7 月 29 日发出。会议由董事长张航女士召集和主持， 应出席董事 7 人，实际出席董事 7 人，公司高级管理人员列席了会议。会议召开程 序符合《公司法》和《公司章程》的有关规定。会议形成如下决议： 一、审议通过《关于董事会换届选举的议案》（表决结果：同意 7 票，反对 0 票，弃权 0 票） 内容详见与本公告同日刊登在上海证券交易所网站上的《山东新华锦国际股份 有限公司关于董事会换届选举的公告》（公告编号：2025-037）的相关内容。 公司拟于 2025 年 8 月 19 日召开 2025 年第一次临时股东会，审议经本次董事会 审议通过的并 ...

Group 1 - The board of directors of Hainan Shuangcheng Pharmaceutical Co., Ltd. held its 19th meeting of the 5th session on July 14, 2025, with all 6 directors present and participating in the voting [1] - The board approved a proposal to provide guarantees for its subsidiary, Ningbo Shuangcheng Pharmaceutical Co., Ltd., with a voting result of 3 in favor, 3 abstentions, and no opposition [2] - The board believes that providing guarantees will help the subsidiary secure funding and promote its business development, while the controlling shareholder will provide a guarantee of the same amount, ensuring manageable risk [2] Group 2 - The proposal for the guarantee will be submitted to the shareholders' meeting for approval, with related shareholders required to abstain from voting [2] - The board also approved a proposal to convene the first temporary shareholders' meeting of 2025, with a unanimous voting result of 6 in favor [2]

Group 1 - The board of directors of Jiangsu Lidao New Materials Co., Ltd. held its 16th meeting on June 23, 2025, with all 9 directors present, and the meeting was conducted in accordance with legal regulations [1] - The board approved the company and its subsidiaries to engage in a bill pool business with domestic commercial banks, with a maximum balance of RMB 700 million [1] - The board also approved several amendments to the company's governance documents, including the Articles of Association, and the cancellation of the supervisory board, which will be submitted for approval at the 2025 first extraordinary general meeting [2][3] Group 2 - The board approved the revision of the Rules of Procedure for Shareholders' Meetings, the Rules of Procedure for Board Meetings, and the Management Measures for the Use of Raised Funds, all requiring approval at the upcoming extraordinary general meeting [2][3] - The board also approved the revision of the Audit Committee Working Rules and the election of members for the board's specialized committees, with all votes in favor [3][4] - The company plans to hold the 2025 first extraordinary general meeting on July 11, 2025 [3]